Clinical Trial Update: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk / World Health Organization (WHO)

View source ↗

Summary

A completed clinical trial evaluated the risk of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection. The update involves the W…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multisystem Inflammatory Syndrome in Children

Snippet

Sponsor: Association Clinique Thérapeutique Infantile du val de Marne | Conditions: Sars-CoV-2 Infection, MIS-C | Status: COMPLETED